Romero Jesús, Benlloch Raquel, Obeso Jorge, Engel Olga, Gil Beatriz, Córdoba Sofía, Zapata Irma, López Marta, Portero Francisca
Servicio de Oncología Radioterápica; Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Servicio de Microbiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Rep Pract Oncol Radiother. 2021 Apr 14;26(2):237-241. doi: 10.5603/RPOR.a2021.0036. eCollection 2021.
The sanitary emergency created by the COVID-19 pandemic forced us to take exceptional measures that affect decision-making and administration of treatments with radiotherapy. The aim of the study was to analyze the impact of the COVID-19 pandemic on patients and professionals in a radiation oncology department.
We implement a plan with the objectives of maintaining radiotherapy treatment in those patients who need it and, at the same time, reducing the risk of spreading the virus to staff and patients. This plan included measures aimed at limiting the patient's stay in hospital, selecting those patients in whom radiotherapy cannot be delayed and protecting against infection through the use of physical protective measures.
Between March 16 and May 31, 2020, 360 patients received radiotherapy in our department. In 14 patients (4.7%) the start of treatment was delayed by an average of 28 days. Four patients had a positive COVID-19 polymerase chain reaction (PCR ) (6.6% and 1.1% of tested and all patients, respectively). Among the professionals, two PCR s were positive (16.6% and 4% of tested and all individuals, respectively). In the serology analysis 4 out of 50 department members were IgG positive (8%).
Despite the fact that our department is located in a region with a high incidence of COVID-19 infection, the impact of the pandemic on our patients and staff has been moderate. The implementation of measures against infection and an adequate selection of patients for treatment allows radiation oncology departments to maintain clinical activity.
2019年冠状病毒病（COVID-19）大流行引发的卫生紧急情况迫使我们采取特殊措施，这些措施影响了放疗治疗的决策和管理。本研究的目的是分析COVID-19大流行对放射肿瘤学部门的患者和专业人员的影响。
我们实施了一项计划，目标是为有需要的患者维持放射治疗，同时降低病毒传播给工作人员和患者的风险。该计划包括旨在限制患者住院时间、挑选那些放疗不能推迟的患者以及通过使用物理防护措施预防感染的措施。
在2020年3月16日至5月31日期间，我们科室有360名患者接受了放疗。14名患者（4.7%）的治疗开始时间平均推迟了28天。4名患者的COVID-19聚合酶链反应（PCR）检测呈阳性（分别占检测患者的6.6%和所有患者的1.1%）。在专业人员中，有2次PCR检测呈阳性（分别占检测人员的16.6%和所有人员的4%）。在血清学分析中，50名科室成员中有4人IgG呈阳性（8%）。
尽管我们科室所在地区COVID-19感染发病率很高，但大流行对我们的患者和工作人员的影响一直较为温和。实施感染防控措施以及对治疗患者进行充分挑选，使得放射肿瘤学科室能够维持临床活动。
